Literature DB >> 15378045

Diagnosing prion diseases: needs, challenges and hopes.

Claudio Soto1.   

Abstract

Prion diseases are among the most intriguing infectious diseases and are associated with unconventional proteinaceous infectious agents known as prions. Prions seem to lack nucleic acid and propagate by transmission of protein misfolding. The nature of prions and their unique mode of transmission present challenges for early diagnosis of prion diseases. In this article, state-of-the-art prion diagnostic techniques, together with the new strategies that are being used to develop sensitive, early and non-invasive diagnoses for these diseases are reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378045     DOI: 10.1038/nrmicro1003

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  26 in total

1.  Reversibility of prion-induced neurodegeneration.

Authors:  Claudio Soto
Journal:  Lancet Neurol       Date:  2007-04       Impact factor: 44.182

2.  Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS.

Authors:  Bruce Onisko; Irina Dynin; Jesús R Requena; Christopher J Silva; Melissa Erickson; John Mark Carter
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-28       Impact factor: 3.109

Review 3.  Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging?

Authors:  Pavlina Sobrova; Iva Blazkova; Jana Chomoucka; Jana Drbohlavova; Marketa Vaculovicova; Pavel Kopel; Jaromir Hubalek; Rene Kizek; Vojtech Adam
Journal:  Prion       Date:  2013-09-20       Impact factor: 3.931

Review 4.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease.

Authors:  Richard Rubenstein; Binggong Chang; Perry Gray; Martin Piltch; Marie S Bulgin; Sharon Sorensen-Melson; Michael W Miller
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

6.  Reduction of prion infectivity in packed red blood cells.

Authors:  Rodrigo Morales; Kimberley A Buytaert-Hoefen; Dennisse Gonzalez-Romero; Joaquin Castilla; Eric T Hansen; Dennis Hlavinka; Raymond P Goodrich; Claudio Soto
Journal:  Biochem Biophys Res Commun       Date:  2008-10-11       Impact factor: 3.575

7.  Concentration of disease-associated prion protein with silicon dioxide.

Authors:  Helen C Rees; Ben C Maddison; Jonathan P Owen; Garry C Whitelam; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2008-12-05       Impact factor: 2.695

8.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

9.  Protein misfolding cyclic amplification of infectious prions.

Authors:  Rodrigo Morales; Claudia Duran-Aniotz; Rodrigo Diaz-Espinoza; Manuel V Camacho; Claudio Soto
Journal:  Nat Protoc       Date:  2012-06-28       Impact factor: 13.491

10.  Detection of infectious prions in urine.

Authors:  Dennisse Gonzalez-Romero; Marcelo A Barria; Patricia Leon; Rodrigo Morales; Claudio Soto
Journal:  FEBS Lett       Date:  2008-08-13       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.